Skip to main content

REVIEW article

Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1467084

The Mechanism of Intracellular Interaction of Antimicrobial Peptides Underlying Bacterial Adaptation Strategies: A review

Provisionally accepted
  • Chosun University, Gwangju, Republic of Korea

The final, formatted version of the article will be published soon.

    The creation of improved predictive models necessitates a thorough understanding of the molecular mechanisms behind AMPs' antibacterial activity. AMPs interact with membranes, causing perturbation, disrupting physiological events like cell wall biosynthesis or cell division, and/or translocating across membranes to target cytoplasmic components. Antibiotic resistance poses a significant threat to human health, prompting the investigation of new countermeasures. Antimicrobial peptides (AMPs), sourced both synthetically and naturally, exhibit broad-spectrum antimicrobial action with high specificity, resulting in minimal bacterial resistance. These peptides possess unique activities and structures, employing diverse mechanisms of action. This study explores the origins, structural characteristics, mechanisms, and context of AMPs' antibacterial and antibiofilm capabilities. AMPs kill bacteria by disrupting membranes or interfering with internal bacterial components. However, a gap remains in understanding the relationship between cytolytic activity across species and AMP structures due to the complex nature of their membrane interactions, which can alter AMP classes by mechanism. Various biophysical methods have been employed to study the impact of peptides and model membrane systems on cytolytic activity. A quantitative analysis of peptide binding to membranes and the resulting dynamic structural changes is crucial for characterizing this interaction. This study has reviewed findings that elucidate the multistep methods used by several AMPs in nature, potentially enhancing our ability to develop a new generation of effective antimicrobial treatments.

    Keywords: antimicrobial peptides, transmembrane, antibiotic, Therapeutic agent, minimum inhibitory concentration

    Received: 19 Jul 2024; Accepted: 19 Sep 2024.

    Copyright: © 2024 Tamanna. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Sadia Tamanna, Chosun University, Gwangju, Republic of Korea

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.